Approximately half of patients with mild-to-moderate asthma have persistently noneosinophilic disease, a disease phenotype that responds poorly to currently available antiinflammatory therapy.
American journal of respiratory and critical care medicine
Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA 94143, USA.
Am J Respir Crit Care Med. 2012 Mar;185(6):612-9
© Galenicom 1999-2013